Connect with us

Technology

Snapchat is developing its own take on TikTok Duets with a new ‘Remix’ feature – Yahoo Finance Australia

One of the challenges that some would-be TikTok rivals have faced is that they often lack the same robust set of content creation tools, like filters…

Published

on

Article feature image

IND accepted for VOR33, Vors lead eHSC product candidate for treatment of AML Completed initial public offering raising $203.4 million in total gross proceeds CAMBRIDGE, Mass., March 25, 2021 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR) (the Company), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today reported financial results for the year ended December 31, 2020, and provided an update on…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending